- Ozempic is a semaglutide medication primarily used for type 2 diabetes and often discussed in relation to weight loss.
- The term “Ozempic” is often used broadly in public conversation, but different GLP-1 medications and brands have different approvals and uses.
- Obesity and type 2 diabetes are chronic medical conditions influenced by biological, behavioral, and environmental factors.
- GLP-1 medications can be effective for some patients, but side effects, contraindications, and follow-up care are important considerations.
- Treatment options for metabolic health may include lifestyle support, medication, and in some cases bariatric or metabolic surgery.
Celebrities with ozempic have become part of a much larger public conversation about weight, diabetes, body image, and modern metabolic medicine. As more well-known people speak in their own words about using Ozempic or related GLP-1 medications, the discussion has shifted from rumor toward openness, context, and clearer health education.
That matters because medications such as Ozempic can carry both medical significance and cultural baggage. Public disclosures do not tell anyone what treatment is right for them, but they can help reduce stigma around obesity, type 2 diabetes, and the realities of long-term health management.
Below is a carefully selected roundup of public figures who have personally and publicly discussed Ozempic. The focus here is on documented, self-disclosed accounts and why those conversations resonated beyond celebrity news.
1. Oprah Winfrey
Oprah Winfrey has spoken openly about using prescription medication as part of weight management after years of public discussion about dieting and body image. In late 2023, she shared publicly that she had come to see weight as a medical issue rather than simply a matter of willpower, and said she used medication as a tool for managing it. Although she discussed the broader class of weight-loss medicines rather than centering a brand alone, her comments were widely understood within the Ozempic-era conversation. Her openness mattered because it challenged longstanding shame-based narratives around obesity and helped frame treatment as part of chronic disease care.
2. Sharon Osbourne
Sharon Osbourne has publicly said she used Ozempic and spoke candidly about the results and downsides she experienced. In 2023, she described losing a significant amount of weight and also expressed concern that she had become too thin, making clear that the experience was not simply glamorous or straightforward. By discussing both the appeal and the drawbacks, she offered a more balanced public account than many headline-driven conversations. Her comments helped underline that these medications can have real effects and are not cosmetic shortcuts without consequences.
3. Amy Schumer
Amy Schumer has shared publicly that she tried Ozempic and later stopped using it because of side effects. In 2023, she spoke in a direct, humorous but still clear way about feeling unwell on the medication and said the experience was not sustainable for her. Because she was open about a negative personal outcome, her comments broadened the conversation beyond celebrity speculation and rapid weight-loss narratives. Her disclosure also reminded audiences that medication responses vary from person to person.
4. Tracy Morgan
Tracy Morgan has spoken publicly about taking Ozempic and linked it to his ongoing health management. He has discussed the medication in the context of appetite changes and his efforts to manage diabetes-related issues, while also joking in his characteristic style about how it affected him. Even with humor, the disclosure was clearly about his own use and his own health. His comments resonated because they connected Ozempic not only with weight headlines but with the treatment of chronic metabolic disease.
5. Chelsea Handler
Chelsea Handler has publicly described being prescribed a semaglutide medication without initially realizing what it was and later stopping it. In 2023, she said her anti-aging doctor had given it to her and that she did not feel it was medically appropriate for her to continue. Her account drew attention because it raised questions about how casually powerful medications can enter lifestyle and wellness conversations. By discussing her own experience openly, she helped spotlight the importance of medical context and appropriate prescribing.
6. Whoopi Goldberg
Whoopi Goldberg has shared publicly that she used a GLP-1 medication for weight loss after a period of illness and recovery, speaking about it in 2024. She explained that the treatment helped her after she had gained weight during a difficult health stretch, and she addressed the subject in a matter-of-fact way rather than as a dramatic reveal. While she referred to the medication class rather than presenting it as a trend story, her comments were part of the wider Ozempic conversation. Her openness contributed to a more grounded understanding of why some patients turn to these drugs.
7. Heather Gay
Heather Gay has publicly said she was using Ozempic, discussing it candidly during the recent wave of celebrity interest in GLP-1 medications. She acknowledged the subject directly rather than deflecting it, and framed it as part of the reality of contemporary weight-loss conversations. That straightforwardness stood out in a media environment often driven by rumor or denial. Her disclosure mattered because it normalized speaking honestly about medical weight-loss treatment without treating it as scandal.
8. Dolores Catania
Dolores Catania has spoken publicly about using Ozempic and later also discussed Mounjaro in the context of menopause, weight change, and health management. She has been unusually direct in saying that many people were thinking about these medications and that she chose to be honest about her own experience. That candor helped separate first-person disclosure from tabloid-style guessing about appearance. Her comments also reflected how weight changes can intersect with midlife hormonal shifts and broader metabolic health concerns.
9. Remi Bader
Remi Bader has shared publicly that she used Ozempic for a period and later stopped, discussing the emotional and physical complexity of that experience. She described changes in appetite and weight as well as the difficulty she felt after discontinuing the medication, including the public scrutiny that surrounded the topic. Because she has built much of her platform around body image and fashion inclusivity, her comments carried particular weight for audiences navigating similar issues. Her openness highlighted that treatment decisions can be deeply personal and psychologically layered.
10. Fat Joe
Fat Joe has publicly discussed using Ozempic as part of his efforts to manage weight and health, speaking about it in connection with lifestyle changes and long-term metabolic concerns. He has described the medication as one tool among others rather than a stand-alone fix. That framing is important because it places the drug within a broader health context rather than reducing it to a celebrity trend. His comments also helped broaden the public image of who uses GLP-1 medications and why.
What Ozempic is
Ozempic is a brand name for semaglutide, a prescription medication in the GLP-1 receptor agonist class. It is primarily approved in many countries for adults with type 2 diabetes, where it is used to help improve blood sugar control. It is given as an injection, typically once weekly, and works by mimicking a natural hormone involved in glucose regulation, insulin release, appetite signaling, and the speed at which the stomach empties.
Public attention around Ozempic has expanded far beyond diabetes because semaglutide can also reduce appetite and contribute to weight loss in some patients. A related semaglutide product is specifically used for chronic weight management under different prescribing criteria. This overlap is one reason the public often uses “Ozempic” as a shorthand for a broader group of GLP-1 medications, even though brand names, approvals, doses, and intended uses are not identical.
These medications are relevant to the treatment of metabolic disease, which includes conditions such as type 2 diabetes, obesity, insulin resistance, and some cardiovascular risk patterns. Obesity is increasingly understood as a chronic, multifactorial health condition influenced by genetics, hormones, environment, medications, sleep, stress, diet, physical activity, and social factors. That is why modern treatment discussions may include behavioral support, nutrition care, exercise planning, medications, and in some cases bariatric surgery.
Like all prescription drugs, Ozempic can have side effects and is not appropriate for everyone. Commonly discussed effects include nausea, vomiting, diarrhea, constipation, reduced appetite, and other gastrointestinal symptoms. There are also important safety considerations, contraindications, and monitoring issues that depend on a person’s medical history. For that reason, celebrity stories can raise awareness, but they should not substitute for individualized medical assessment.
Diagnosis and treatment landscape
Ozempic is not a diagnosis in itself; rather, it is one option within the management of certain metabolic conditions. Diagnosis of type 2 diabetes generally involves blood glucose testing and assessment of long-term glucose markers, while evaluation of overweight or obesity may include body-mass index, waist measurement, metabolic labs, blood pressure, sleep and lifestyle history, medication review, and screening for related conditions. Clinicians also consider whether weight gain or blood sugar problems may be linked to endocrine disorders, medications, or other medical causes.
Treatment plans vary. For type 2 diabetes, care may include nutrition changes, exercise, oral medications, GLP-1 receptor agonists such as semaglutide, insulin, and cardiovascular risk reduction. For obesity, treatment may include structured lifestyle intervention, mental health support when needed, anti-obesity medications, and metabolic or bariatric surgery for selected patients. The best approach depends on a person’s diagnosis, goals, comorbidities, prior treatment history, and tolerance of therapy.
One important issue in the Ozempic conversation is expectation management. Some people experience meaningful benefits, while others have side effects, limited response, weight regain after stopping, or difficulty accessing medication. Long-term treatment planning matters because obesity and diabetes are often chronic conditions rather than short-term problems. Continuing follow-up helps monitor effectiveness, side effects, nutrition, and broader health outcomes.
There is also a larger public-health lesson here: reducing stigma can improve care. When weight and metabolic disease are discussed only in terms of appearance or self-control, people may delay diagnosis or avoid treatment. A more constructive framework recognizes that these are medical conditions deserving evidence-based evaluation. For readers interested in the wider medical landscape of obesity care, our overview of Bariatric & Metabolic Surgery explains another established treatment pathway for selected patients.
As research continues, GLP-1 medications are likely to remain an important part of metabolic medicine. But they are best understood not as a cultural fad, but as one set of tools within a broader continuum of care.
Explore Bariatric & Metabolic Surgery at Acibadem →
Frequently asked questions
Is Ozempic the same as a weight-loss drug?
Ozempic is a brand of semaglutide mainly used for type 2 diabetes, although semaglutide is also used in other formulations for chronic weight management. Public discussion often blurs these distinctions, so the specific brand, dose, and indication matter.
Why do people talk about Ozempic and obesity together?
Semaglutide can affect appetite and energy intake, so it has become part of the broader conversation about obesity treatment. That does not mean it is appropriate for everyone, and obesity care usually involves more than one strategy.
Can celebrity stories tell you whether Ozempic is right for you?
No. Public figures can help reduce stigma by sharing their own experiences, but treatment decisions depend on an individual’s diagnosis, health history, goals, and risk profile.
What other treatments exist for metabolic disease besides Ozempic?
Options may include nutrition and activity programs, other diabetes or anti-obesity medications, mental health support, cardiovascular risk management, and for selected patients, bariatric or metabolic surgery.
✔ Reviewed by the Acibadem medical team
This article is general health information inspired by publicly reported news. It is not a statement about any individual’s private medical care, nor medical advice. Always consult a qualified clinician.